tyloxapol has been researched along with Familial Hypobetalipoproteinemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Averna, MR; Chen, Z; Fitzgerald, RL; Schonfeld, G | 1 |
1 other study(ies) available for tyloxapol and Familial Hypobetalipoproteinemia
Article | Year |
---|---|
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
Topics: Animals; Apolipoprotein B-100; Apolipoproteins B; Base Sequence; Cells, Cultured; Cholesterol; Fatty Liver; Hepatocytes; Humans; Hypobetalipoproteinemias; Intestine, Small; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Transgenic; Phospholipids; Polyethylene Glycols; Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Nucleic Acid; Surface-Active Agents; Triglycerides | 2000 |